title: Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
abstract: The cartilage oligomeric matrix protein (COMP) is a glycoprotein, which occurs mainly in an articular cartilage. The amount of this protein increases under the influence of cytokines and growth factors. As a result of various diseases that cause damage to cartilage, fragments of matrix protein are released into synovial fluid and then into blood. The assessment of matrix protein level in serum, for example COMP, permits the establishment of the degree of cartilage damage in inflammatory joint diseases, and permits observation of the effectiveness of the treatment. Blood was collected from 30 systemic lupus erythematosus (SLE) patients, and from 30 patients with knee osteoarthritis (OA) who constituted the control group. Serum COMP level was determined using an inhibition enzyme-linked immunosorbent assay (ELISA). The average value of the serum COMP level in SLE patients was 11.3+/-3.7 U/l. According to correlation coefficients, serum COMP level is independent of patients' age, disease duration and the clinical picture of SLE. No correlation was found between serum COMP level and bone mass density (BMD) changes. In SLE patients with decreased haemoglobin levels (<11.0 g/dl) values compared with patients with normal haemoglobin level, the serum COMP level was observed to be significantly higher (P<0.05). Both in SLE patients with erythrocyte sedimentation rate (ESR) values over 60 mm/h and in patients with ESR values below 60 mm/h, the serum COMP level was observed to be significantly higher (P<0.05). A significant positive correlation was found between serum COMP level and ESR value, as well as a number of thrombocytes. Negative correlation occurred between the serum COMP level and the value of haemoglobin. The average value of COMP in OA patients was 10.4+/-2.7 U/l. No correlation was found between serum COMP level and patients' age and disease duration. There was correlation between the serum COMP level and the T-score value of densitometry examinations in OA patients. No statistical differences were found between the average serum COMP levels for SLE and OA patients.
authors.affiliation: Department of Rheumatology, Central Clinical Hospital, Woloska 137, 02-507, Warsaw, Poland. mwislowska@wp.pl
authors.forename: M
authors.initials: M
authors.lastname: Wisłowska
authors.forename: B
authors.initials: B
authors.lastname: Jabłońska
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001799:Blood Sedimentation; D015519:Bone Density; D002097:C-Reactive Protein / Q000032:analysis; D064236:Cartilage Oligomeric Matrix Protein; D019963:Clinical Chemistry Tests; D004797:Enzyme-Linked Immunosorbent Assay; D016326:Extracellular Matrix Proteins / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000000981:diagnostic imaging / Q000503:physiopathology; D008297:Male; D064235:Matrilin Proteins; D008875:Middle Aged; D009961:Orosomucoid / Q000032:analysis; D020370:Osteoarthritis, Knee / Q000097:blood* / Q000000981:diagnostic imaging / Q000503:physiopathology; D011859:Radiography
chemical_list: D015415:Biomarkers; D064236:Cartilage Oligomeric Matrix Protein; D016326:Extracellular Matrix Proteins; D006023:Glycoproteins; D006454:Hemoglobins; D064235:Matrilin Proteins; D009961:Orosomucoid; C577553:TSP5 protein, human; D002097:C-Reactive Protein
references.citation: Arthritis Rheum. 1997 Sep;40(9):1725
references.pmid: 9324032
references.citation: Br J Rheumatol. 1997 Nov;36(11):1161-5
references.pmid: 9402859
references.citation: Semin Arthritis Rheum. 1991 Jun;20(6 Suppl 2):40-7
references.pmid: 1866629
references.citation: Arthritis Rheum. 1997 Sep;40(9):1612-8
references.pmid: 9324015
references.citation: Eur J Biochem. 1994 Aug 1;223(3):927-37
references.pmid: 8055970
references.citation: Osteoarthritis Cartilage. 1998 Jan;6(1):33-9
references.pmid: 9616437
references.citation: FASEB J. 1989 Jul;3(9):2042-51
references.pmid: 2663581
references.citation: Br J Rheumatol. 1997 Aug;36(8):847-9
references.pmid: 9291852
references.citation: Arthritis Rheum. 1982 Nov;25(11):1271-7
references.pmid: 7138600
references.citation: J Clin Invest. 1995 Mar;95(3):1071-7
references.pmid: 7533784
references.citation: Differentiation. 1987;36(3):199-210
references.pmid: 3449399
references.citation: J Biol Chem. 1992 Mar 25;267(9):6137-41
references.pmid: 1556122
references.citation: Osteoarthritis Cartilage. 2002 Sep;10 (9):707-13
references.pmid: 12202123
references.citation: Br J Rheumatol. 1997 Nov;36(11):1151-60
references.pmid: 9402858
references.citation: J Biol Chem. 1992 Mar 25;267(9):6132-6
references.pmid: 1556121
references.citation: Br J Rheumatol. 1992 Sep;31(9):583-91
references.pmid: 1381980
references.citation: Arthritis Res Ther. 2003;5(4):R181-5
references.pmid: 12823852
references.citation: Ann Rheum Dis. 2002 Apr;61(4):311-8
references.pmid: 11874832
references.citation: Br J Rheumatol. 1992 Sep;31(9):593-8
references.pmid: 1525624